-
Correction to: Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
-
Carbapenem resistance in community-acquired urinary tract infections caused by Klebsiella pneumoniae and Escherichia coli in Morocco: a multicentre study (January 2022–December 2023)‘Carbapenem resistance in community UTIs in Morocco’
-
Bacteremic versus Non-Bacteremic Urinary Tract Infections: Predictors of Poor Clinical Outcome
-
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
-
Microbiological findings, antibiotic resistance rates and prescription practices for older women with recurrent urinary tract infections: a descriptive study alongside a multinational randomized controlled trial (ImpresU)
-
Performance of carbapenemase screening algorithms for detection of OXA-244-producing Escherichia coli
-
P57 Comparative analysis of antibiotic susceptibility in Escherichia coli using the agar disc diffusion method
-
P88 Enhancing host-microbiota synergy: fruit by-product polyphenols as prebiotic adjuvants to prevent pathogenic Escherichia coli colonization
-
Defining a target product profile for antimicrobials to treat severe paediatric bacterial enteric infections in low- and medium-income countries, caused by E. coli, Shigella, Salmonella and Campylobacter species
-
A study of urinary tract infections in renal transplant patients
-
From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies
-
Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
-
Treatment outcomes of daptomycin- and vancomycin-resistant Enterococcus faecium bloodstream infection
-
P86 1990–2021 trend in fatal burden from infections resistant to antibiotics across the UK background
-
Epidermicin NI01 demonstrates potent in vivo activity in a murine model of methicillin-resistant Staphylococcus aureus skin infection
-
Incidence proportion and divergent performance of risk factors for carbapenem-resistant Gram-negative bacteria bloodstream infections across haematological cohorts
-
ADVANCE-ID bacterial and fungal infections review: antimicrobial resistance research updatesSummary of clinical trials and implementation studies, March–April 2026
-
Prognosis prediction by urinary liver-type fatty acid-binding protein in patients in the intensive care unit admitted from the emergency department: A single-center, historical cohort study
-
Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa
-
P58 From awareness to action: bridging the knowledge – practice gap in antimicrobial resistance in Nigeria—a systematic review of community-based strategies
-
A Case of Ileal Conduit Bleeding Caused by Porto‐Sinusoidal Vascular Disorder
-
Therapeutic Interaction Features of AI Chatbots in Depression Interventions: Systematic Review and Meta-Analysis
-
Digital therapeutics in peripheral artery disease: a step forward, not yet across the finish line
-
P66 Multi-country synthesis of antimicrobial stewardship implementation in low- and middle-income countries: facilitators, barriers, and strategies across Bangladesh, Nigeria and India
